Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Long-Term Investments (2016 - 2019)

Historic Long-Term Investments for Immucell (ICCC) over the last 6 years, with Q1 2019 value amounting to $4117.0.

  • Immucell's Long-Term Investments fell 9569.16% to $4117.0 in Q1 2019 from the same period last year, while for Mar 2019 it was $4117.0, marking a year-over-year decrease of 9569.16%. This contributed to the annual value of $40209.0 for FY2018, which is 5792.15% down from last year.
  • Immucell's Long-Term Investments amounted to $4117.0 in Q1 2019, which was down 9569.16% from $40209.0 recorded in Q4 2018.
  • Immucell's Long-Term Investments' 5-year high stood at $489648.0 during Q4 2015, with a 5-year trough of $4117.0 in Q1 2019.
  • Over the past 5 years, Immucell's median Long-Term Investments value was $96973.5 (recorded in 2017), while the average stood at $236376.1.
  • In the last 5 years, Immucell's Long-Term Investments crashed by 128.06% in 2015 and then tumbled by 9569.16% in 2019.
  • Over the past 5 years, Immucell's Long-Term Investments (Quarter) stood at $489648.0 in 2015, then decreased by 0.54% to $487000.0 in 2016, then plummeted by 80.38% to $95557.0 in 2017, then tumbled by 57.92% to $40209.0 in 2018, then plummeted by 89.76% to $4117.0 in 2019.
  • Its Long-Term Investments was $4117.0 in Q1 2019, compared to $40209.0 in Q4 2018 and $98390.0 in Q3 2018.